Increased microglial activation of NF-κB (by EMSA and phospho-p65 immunoblot) in spinal cord of both human patients with ALS and in the SOD1-G93A mouse model of ALS has been shown to parallel disease progression (108). The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.